Singapore Business Channel: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Singapore Business Channel.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on February 24, 2026

Feb. 24, 2026

SparQ by Kagool Is Certified by SAP® for clean core with SAP S/4HANA Cloud

EIN Presswire

Feb. 24, 2026

Castles Technology Selects Bright Pattern to Modernize Global Customer Support

EIN Presswire

Feb. 24, 2026

Enigmatig Mengumumkan Pertumbuhan Hasil 12.2% & Margin Kasar 68.8% Tahun Fiskal 2025 Selepas Penyenaraian di NYSE American

GlobeNewswire

Feb. 24, 2026

Enigmatig 公佈 2025 財政年度業績，於美國紐約證交所上市後，收入錄得 12.2% 增幅，毛利率達 68.8%

GlobeNewswire

Feb. 24, 2026

Enigmatig Melaporkan Pertumbuhan Pendapatan 12,2% dan Margin Bruto 68,8% pada Tahun Fiskal 2025 Setelah Pencatatan Saham (Listing) di NYSE American

GlobeNewswire

Feb. 24, 2026

エニグマティック、NYSEアメリカン上場後、2025年度に12.2%の売上高成長と68.8%の売上総利益率を報告

GlobeNewswire

Feb. 24, 2026

Enigmatig, 미국 NYSE 상장 후 2025 회계연도 매출 12.2%, 매출총이익 68.8% 성장 기록

GlobeNewswire

Feb. 24, 2026

Enigmatig รายงานรายได้เติบโต 12.2% และอัตรากำไรขั้นต้น 68.8% ในปีงบประมาณ 2025 หลังจากเข้าจดทะเบียนในตลาดหลักทรัพย์ NYSE America…

GlobeNewswire

Feb. 24, 2026

CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China

GlobeNewswire